Integrated Shield Plan (IP) insurers introduce key initiatives to support IP policyholders amid implementation of the Ministry of Health’s Cancer Drug List
Launch of extended panel and update of standard pre-authorisation form complement larger panels to increase patient accessibility to specialist and improve patient care
